Showing results (631-640 of 812) with videos related to

Sort By:
Pageof 82
Oncotarget|May 3, 2018
2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancerLokesh Dalasanur Nagaprashantha, Jyotsana Singhal, Hongzhi Li, et al.
International Journal of Cancer|November 4, 1996
Modulation of doxorubicin cytotoxicity by ethacrynic acidS Awasthi, S S Singhal, N He, et al.
Bone Marrow Transplantation|April 15, 2008
The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patientsB Sirohi, R Powles, J Treleaven, et al.
Critical Reviews in Oncology/Hematology|February 5, 2026
Emerging Trends and Treatment Strategies in Ovarian Cancer: A Comprehensive ReviewB Madhu Krishna, Pankaj Garg, Sravani Ramisetty, et al.
Bone Marrow Transplantation|August 6, 1999
Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapyS Singhal, J Mehta, K Desikan, et al.
Bone Marrow Transplantation|May 19, 2006
Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemiaS Trifilio, L Gordon, S Singhal, et al.
Stem Cells (Dayton, Ohio)|August 1, 1995
Maintenance therapy for remission in myeloma with Intron A following high-dose melphalan and either an autologous bone marrow transplantation or peripheral stem cell rescueR Powles, N Raje, D Cunningham, et al.
Oncotarget|March 9, 2022
Correction: 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancerLokesh Dalasanur Nagaprashantha, Jyotsana Singhal, Hongzhi Li, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
PCSK9 and High-Fat Diet Synergistically Induce Neurovascular Dysfunction and NeuroinflammationMengqi Zhang, Anudari Letian, Gregory A Mohl, et al.
Leukemia & Lymphoma|May 1, 1996
Comparison of interferon tolerance after autologous bone marrow or peripheral blood stem cell transplants for myeloma patients who have responded to induction therapyR Powles, N Raje, C Horton, et al.
Pageof 82